Skip to main content
. 2015 Oct 15;11(10):e1004314. doi: 10.1371/journal.pcbi.1004314

Fig 7. Model diagram showing receptor level treatment implementation.

Fig 7

The extracorporeal treatment introduces a trapped receptor state for CXCR-1/2. This state prevents IL-8 induced phenotype transition, which limits NK generation. The treatment is modeled entirely in the receptor level of model, leaving the systemic level (see Fig 1) unchanged.